A Low-Dose Oxytocin Protocol Decreases Quantitative Blood Loss in Elective Cesarean Sections: A Single-Center, Retrospective Cohort Study.

This article focuses on comparing quantitative blood loss (QBL) after elective cesarean deliveries using the Defense Health Agency’s (DHA) standardized low-dose oxytocin protocol versus a historically used high-dose strategy. The DHA’s protocol, issued in 2021 as part of the Postpartum Hemorrhage Bundle, involves a lower initial bolus and a regulated infusion of oxytocin, aiming to reduce postpartum hemorrhage (PPH). In a retrospective cohort study of low-risk patients, no statistically significant difference in blood loss or PPH incidence was found between the low-dose and high-dose groups after controlling for confounding factors. The study concludes that the DHA low-dose oxytocin protocol is as effective as high-dose regimens in managing uterine atony during elective cesarean deliveries, recommending further research on side effects, high-risk populations, and transfusion outcomes.